Insertion of Inferior Vena Cava Filters in Patients with the Antiphospholipid Syndrome

Zifman, Eyal; Rotman-Pikielny, Pnina; Berlin, Tatiana; Levy, Yair

doi:10.1016/j.semarthrit.2008.01.016

Cited by 6 publications

(2 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In clinical situations where anticoagulation is not possible or not advisable, consideration is often given for the placement of an IVC filter to prevent propagation of clots. Limited case reports on the use of permanent filters suggested that clot formation can still occur proximal and distal to the filter and recurrent pulmonary emboli may still be seen (6,11). Cherian et al found clots on the proximal side of the filter (6).…”

Section: Discussionmentioning

confidence: 99%

Safety of retrievable inferior vena cava filters in patients with the antiphospholipid syndrome

2018

View full text Add to dashboard Cite

Objective: Consideration for placement of an inferior cava filter arises in patients with APS where cessation of anticoagulation is necessary or thrombotic complications continue despite maximal anticoagulation. Permanent IVC filters are recommended to be avoided. We evaluated the safety of placement and removal of retrievable inferior vena cava filters in patients with APS. Methods: Case series of 5 patients with APS and aPL antibodies who had placement and removal of retrievable IVC filter (because of contraindication to anticoagulation or ongoing thrombosis despite full anticoagulation) to assess for safety, presence of clots in the vena cava or on the filter while in the body, evidence of PE, or clot on the explanted filter. Results: Insertion and removal, even while on anticoagulation, was safe. There was no evidence of clot in the vena cava, on the filter or pulmonary embolism in all cases. Conclusion: Where necessary, retrievable IVC filters may be safer in APS patients but should not be left in for long periods of time.

show abstract

Section: Discussionmentioning

confidence: 99%

Safety of retrievable inferior vena cava filters in patients with the antiphospholipid syndrome

2018

View full text Add to dashboard Cite

show abstract

“…In this situation he was at risk for the development of CTEPH that usually has a fatal outcome in APS patients [4]. Together with the patient and his parents, we decided against plasmapheresis [17] or local therapies like thrombolysis [18][19][20] or vena cava filter [21,22].…”

Section: Discussionmentioning

confidence: 99%

Recurrent pulmonary embolism in a boy with antiphospholipid syndrome

Müller¹,

Willaschek²,

Borst³

et al. 2013

CRCM

View full text Add to dashboard Cite

We report a 14-year-old patient with recurrent pulmonary embolism due to catastrophic antiphospholipid syndrome (APS) with severe pulmonary inflammation. We considered elevated antibodies against cardiolipin and anti-beta2glycoprotein-1, but no clinical nor laboratory manifestations of systemic lupus erythematosus (SLE). Pulmonary embolism had been the first manifestation of catastrophic APS in this patient. We prescribed warfarin and systemic corticosteroids. A second embolism appeared during anticoagulation with warfarin. This event led to a marked decrease of his physical performance due to his obstructive and restrictive lung disease. Anticoagulation was changed from enteral warfarin to subcutaneous enoxaparine. We also prescribed inhaled corticosteroid which led to an improvement of his respiratory symptoms and overall poor physical condition.

show abstract

Perioperative Management of Antiphospholipid Antibody Positive Patients During Noncardiac Surgeries

Saunders

Erkan

2012

Perioperative Management of Patients With Rheumatic Disease

View full text Add to dashboard Cite

Insertion of Inferior Vena Cava Filters in Patients with the Antiphospholipid Syndrome

Cited by 6 publications

References 19 publications

Safety of retrievable inferior vena cava filters in patients with the antiphospholipid syndrome

Safety of retrievable inferior vena cava filters in patients with the antiphospholipid syndrome

Recurrent pulmonary embolism in a boy with antiphospholipid syndrome

Perioperative Management of Antiphospholipid Antibody Positive Patients During Noncardiac Surgeries

Contact Info

Product

Resources

About